Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Cancer care in Needle Hospital, Hargeisa, Somaliland

Gebrekirstos Hagos - Needle Hospital, Hargeisa, Somaliland
Cancer care in Needle Hospital, Hargeisa, Somaliland ( Gebrekirstos Hagos - Needle Hospital, Hargeisa, Somaliland )
5 Dec 2023

Cabozantinib shows clinically meaningful improvement in advanced neuroendocrine tumours

Dr Jennifer Chan - Dana-Farber Cancer Institute, Boston, USA
Cabozantinib shows clinically meaningful improvement in advanced neuroendocrine tumours ( Dr Jennifer Chan - Dana-Farber Cancer Institute, Boston, USA )
7 Nov 2023

Tisotumab vedotin shows clinically meaningful OS improvement versus chemo for metastatic cervical cancer

Prof Ignace Vergote - UZ Leuven, Leuven, Belgium
Tisotumab vedotin shows clinically meaningful OS improvement versus chemo for metastatic cervical cancer ( Prof Ignace Vergote - UZ Leuven, Leuven, Belgium )
7 Nov 2023

CAR-T therapy and impact to cancer patient outcomes and experience of treatment

Mr Matthias Hellberg-Naegele - Cantonal Hospital St Gallen, St Gallen, Switzerland
CAR-T therapy and impact to cancer patient outcomes and experience of treatment ( Mr Matthias Hellberg-Naegele - Cantonal Hospital St Gallen, St Gallen, Switzerland )
7 Nov 2023

Pembrolizumab plus chemoradiotherapy shows clinically meaningful improvement in PFS for locally advanced cervical cancer

Prof Domenica Lorusso - Fondazione IRCCS National Cancer Institute, Milan, Italy
Pembrolizumab plus chemoradiotherapy shows clinically meaningful improvement in PFS for locally advanced cervical cancer ( Prof Domenica Lorusso - Fondazione IRCCS National Cancer Institute, Milan, Italy )
7 Nov 2023

2 year recurrence free survival benefit for resectable melanoma treated with neoadjuvant/adjuvant pembrolizumab

Dr Sapna Patel - MD Anderson Cancer Center, Houston, USA
2 year recurrence free survival benefit for resectable melanoma treated with neoadjuvant/adjuvant pembrolizumab ( Dr Sapna Patel -  MD Anderson Cancer Center, Houston, USA )
2 Nov 2023

McVie-Veronesi Awards: 3rd Prize - Role of sentinel lymph node biopsy in node positive breast cancer patients? Converting to node negativity after neoadjuvant chemotherapy

Dr Akella Phanedra - TATA medical center, Kolkata, India
McVie-Veronesi Awards: 3rd Prize - Role of sentinel lymph node biopsy in node positive breast cancer patients? Converting to node negativity after neoadjuvant chemotherapy ( Dr Akella Phanedra - TATA medical center, Kolkata, India )
11 Oct 2023

Cost-benefit analysis of new cancer medicines: The difficult choices of governments

Dr Nwamaka Lasebikan, Prof P.G. Roy, Dr Didier Verhoeven
Cost-benefit analysis of new cancer medicines: The difficult choices of governments ( Dr Nwamaka Lasebikan, Prof P.G. Roy, Dr Didier Verhoeven )
8 Oct 2023

OncoAlert Round Up for September 15-21, 2023

Dr Gil Morgan - Executive Director, OncoAlert
OncoAlert Round Up for September 15-21, 2023 ( Dr Gil Morgan - Executive Director, OncoAlert )
25 Sep 2023

Osimertinib plus chemotherapy shows superior results versus osimertinib alone for EGFR-mutated advanced lung cancer

Prof Pasi Janne - Dana Farber Cancer Institute, Boston, USA
Osimertinib plus chemotherapy shows superior results versus osimertinib alone for EGFR-mutated advanced lung cancer ( Prof Pasi Janne - Dana Farber Cancer Institute, Boston, USA )
21 Sep 2023

A reproducibility study in pulmonary adenocarcinomas supports a revised classification

Dr Erik Thunnissen - VU University Medical Center, Amsterdam, The Netherlands
A reproducibility study in pulmonary adenocarcinomas supports a revised classification ( Dr Erik Thunnissen - VU University Medical Center, Amsterdam, The Netherlands )
12 Sep 2023

OncoAlert Round Up for September 1-7, 2023

Dr Gil Morgan - Executive Director, OncoAlert
OncoAlert Round Up for September 1-7, 2023 ( Dr Gil Morgan - Executive Director, OncoAlert )
12 Sep 2023